173 related articles for article (PubMed ID: 21229874)
1. Use of hyphenated LC-MS/MS technique for characterization of impurity profile of quetiapine during drug development.
Stolarczyk EU; Kutner A
Acta Pol Pharm; 2010; 67(6):599-608. PubMed ID: 21229874
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of potential impurities of quetiapine fumarate.
Stolarczyk EU; Kaczmarek L; Eksanow K; Kubiszewski M; Glice M; Kutner A
Pharm Dev Technol; 2009; 14(1):27-37. PubMed ID: 18815940
[TBL] [Abstract][Full Text] [Related]
3. Applications of hyphenated LC-MS techniques in pharmaceutical analysis.
Ermer J; Vogel M
Biomed Chromatogr; 2000 Oct; 14(6):373-83. PubMed ID: 11002275
[TBL] [Abstract][Full Text] [Related]
4. The use of LC/MS, GC/MS, and LC/NMR hyphenated techniques to identify a drug degradation product in pharmaceutical development.
Pan C; Liu F; Ji Q; Wang W; Drinkwater D; Vivilecchia R
J Pharm Biomed Anal; 2006 Feb; 40(3):581-90. PubMed ID: 16242883
[TBL] [Abstract][Full Text] [Related]
5. Identification, characterization and quantification of a new impurity in deferasirox active pharmaceutical ingredient by LC-ESI-QT/MS/MS.
Thomas S; Chandra Joshi S; Vir D; Agarwal A; Rao RD; Sridhar I; Xavier CM; Mathela CS
J Pharm Biomed Anal; 2012 Apr; 63():112-9. PubMed ID: 22361658
[TBL] [Abstract][Full Text] [Related]
6. Identification of an unknown trace-level impurity in bulk drug of Seroquel by high-performance liquid chromatography combined with mass spectrometry.
Xu H; Wang D; Sun C; Pan Y; Zhou M
J Pharm Biomed Anal; 2007 Jun; 44(2):414-20. PubMed ID: 17420108
[TBL] [Abstract][Full Text] [Related]
7. LC-MS characterization of trace impurities contained in calcium folinate.
Francese G; Corana F; Meneghetti O; Marazza F
J Pharm Biomed Anal; 2005 Sep; 39(3-4):757-63. PubMed ID: 15927438
[TBL] [Abstract][Full Text] [Related]
8. Application of LC-MS(n) in conjunction with mechanism-based stress studies in the elucidation of drug impurity structure: rapid identification of a process impurity in betamethasone 17-valerate drug substance.
Li M; Lin M; Rustum A
J Pharm Biomed Anal; 2008 Dec; 48(5):1451-6. PubMed ID: 18977106
[TBL] [Abstract][Full Text] [Related]
9. Identification and structural elucidation of an unknown impurity in carbamazepine active pharmaceutical ingredient by liquid chromatography-tandem mass spectrometry and semi-preparative chromatographic isolation.
Thomas S; Mathela CS; Agarwal A; Paul SK
J Pharm Biomed Anal; 2011 Sep; 56(2):423-8. PubMed ID: 21676571
[TBL] [Abstract][Full Text] [Related]
10. Structural elucidation of a process-related impurity in ezetimibe by LC/MS/MS and NMR.
Raman B; Sharma BA; Butala R; Ghugare PD; Kumar A
J Pharm Biomed Anal; 2010 May; 52(1):73-8. PubMed ID: 20079995
[TBL] [Abstract][Full Text] [Related]
11. Time resolved analysis of quetiapine and 7-OH-quetiapine in hair using LC/MS-MS.
Binz TM; Yegles M; Schneider S; Neels H; Crunelle CL
Forensic Sci Int; 2014 Sep; 242():200-203. PubMed ID: 25072665
[TBL] [Abstract][Full Text] [Related]
12. Development, validation and transfer into a factory environment of a liquid chromatography tandem mass spectrometry assay for the highly neurotoxic impurity FMTP (4-(4-fluorophenyl)-1-methyl-1,2,3,6-tetrahydropyridine) in paroxetine active pharmaceutical ingredient (API).
Borman PJ; Chatfield MJ; Crowley EL; Eckers C; Elder DP; Francey SW; Laures AM; Wolff JC
J Pharm Biomed Anal; 2008 Dec; 48(4):1082-9. PubMed ID: 18835674
[TBL] [Abstract][Full Text] [Related]
13. A critical review on the use of modern sophisticated hyphenated tools in the characterization of impurities and degradation products.
Singh S; Handa T; Narayanam M; Sahu A; Junwal M; Shah RP
J Pharm Biomed Anal; 2012 Oct; 69():148-73. PubMed ID: 22521633
[TBL] [Abstract][Full Text] [Related]
14. Study of impurity carryover and impurity profile in Febuxostat drug substance by LC-MS/MS technique.
Kadivar MH; Sinha PK; Kushwah D; Jana P; Sharma H; Bapodra A
J Pharm Biomed Anal; 2011 Dec; 56(4):749-57. PubMed ID: 21840659
[TBL] [Abstract][Full Text] [Related]
15. Comparison of impurity profiles of Orlistat pharmaceutical products using HPLC tandem mass spectrometry.
Schneider A; Wessjohann LA
J Pharm Biomed Anal; 2010 Nov; 53(3):767-72. PubMed ID: 20570457
[TBL] [Abstract][Full Text] [Related]
16. Structural studies of impurities of risperidone by hyphenated techniques.
Sattanathan P; Babu JM; Vyas K; Reddy RB; Rajan ST; Sudhakar P
J Pharm Biomed Anal; 2006 Feb; 40(3):598-604. PubMed ID: 16316737
[TBL] [Abstract][Full Text] [Related]
17. A validated stability-indicating LC method for acetazolamide in the presence of degradation products and its process-related impurities.
Srinivasu P; Subbarao DV; Vegesna RV; Sudhakar Babu K
J Pharm Biomed Anal; 2010 May; 52(1):142-8. PubMed ID: 20053517
[TBL] [Abstract][Full Text] [Related]
18. Improving the detection of degradants and impurities in pharmaceutical drug products by applying mass spectral and chromatographic searching.
Freed AL; Kale U; Ando H; Rossi DT; Kingsmill CA
J Pharm Biomed Anal; 2004 Jun; 35(4):727-38. PubMed ID: 15193717
[TBL] [Abstract][Full Text] [Related]
19. Identification, synthesis and quantification of process-related impurities in auraptene.
Li YG; Chen HF; Tu MZ; Zhang PZ; Wang XY; Yuan JB; Yang WL
J Pharm Biomed Anal; 2011 Sep; 56(2):191-9. PubMed ID: 21705169
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the utility of ion mobility separation in combination with high-pressure liquid chromatography/mass spectrometry to facilitate detection of trace impurities in formulated drug products.
Eckers C; Laures AM; Giles K; Major H; Pringle S
Rapid Commun Mass Spectrom; 2007; 21(7):1255-63. PubMed ID: 17340559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
